Acceleron Pharma

Developer of protein therapeutics to treat cancer and rare blood disorders

placeCambridge, Massachusetts, United States calendar_todayFounded 2004 groups312 employees language acceleronpharma.com

Innovation

148 patent families (97 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Electricity & electronics; filing pace slowing. Cited 63,032 times.

YearFilings
201544
201656
201756
201861
201966
202068
202173
202272
202350
202446
202538
20268

Investor mix

15 investors on record; lead investors include Celgene, Alkermes, Avalon Ventures, Bessemer Venture Partners; 3 have since exited.

Investor typeCountShare
Venture capital1067%
Private equity17%
Bank & private debt17%
Other / undisclosed320%
Coming soon